Predicting life expectancy in prostate cancer patients

Current Opinion in Supportive and Palliative Care

Volumn 3, Issue 3, 2009, Pages 166-169

  Jeldres, Claudio ^a   Latouff, Jean Baptiste ^a   Saad, Fred ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Life expectancy; Nomogram; Prostate cancer

Indexed keywords

ARTICLE; COMORBIDITY; DECISION MAKING; HUMAN; LIFE EXPECTANCY; LIFE TABLE; MALE; PROGNOSIS; PROSTATE TUMOR; RISK ASSESSMENT;

COMORBIDITY; DECISION MAKING; HUMANS; LIFE EXPECTANCY; LIFE TABLES; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 74549150218     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32832e9c80     Document Type: Article

References (23)

1. Scardino P. Update: NCCN prostate cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 2005; 3 (Suppl 1):S29-S33.
2. Heindenreich A, Gunnar A, Bolla M, et al. EAU Guidelines on Prostate Cancer. Eur Urol 2008; 53:68-80.
3. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293:2095- 2101. (Pubitemid 40617061)
4. Ruchlin HS, Pellissier JM. An economic overview of prostate carcinoma. Cancer 2001; 92:2796-2810.
5. Arias E. United States life tables, 2003. Natl Vital Stat Rep 2006; 54:1-40.
6. Alibhai SM, Naglie G, Nam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003; 21:3318-3327. (Pubitemid 46606266)
7. Alibhai SM, Krahn MD, Cohen MM, et al. Is there age bias in the treatment of localized prostate carcinoma? Cancer 2004; 100:72-81.
8. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000; 283:3217-3222.
9. Yan Y, Carvalhal GF, Catalona WJ, et al. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 2000; 88:112-1130.
10. Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 2007; 100:1254-1258.
11. Chow E, Davis L, Panzarella T, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 2005; 61:870-873.
12. Henderson R, Jones M, Stare J. Accuracy of point predictions in survival analysis. Stat Med 2001; 20:3083-3096.
13. Statistics Canada. Complete life table, Quebec 2000-2002: Males. Available at http://www.statcan.ca/english/freepub/84-537.XIE/tables.htm. (Accessed 20 December 2006).
14. Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006; 175:99-103.
15. Tewari A, Johnson CC, Divine G, et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004; 171:1513-1519.
16. Albertsen PC, Fryback DG, Storer BE, et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996; 156:127-132.
17. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285:2750-2756.
18. Walz J, Gallina A, Hutterer G, et al. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007; 69:88-94. (Pubitemid 47247498)
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
20. Greenfield S, Apolone G, McNeil BJ, et al. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993; 31:141-154.
21. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993; 32:382-387.
22. Hall WH, Jani AB, Ryu JK, et al. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 2005; 8:22-30.
23. Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007; 25:3576-3581. The most accurate published tool to assess life expectancy in patients with diagnosed prostate cancer. (Pubitemid 47372594)